GALDIERO, MARIA ROSARIA
 Distribuzione geografica
Continente #
AS - Asia 3.122
EU - Europa 2.411
NA - Nord America 2.411
SA - Sud America 459
AF - Africa 122
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.535
Nazione #
US - Stati Uniti d'America 2.307
SG - Singapore 1.679
RU - Federazione Russa 1.289
CN - Cina 675
IT - Italia 442
BR - Brasile 372
HK - Hong Kong 270
VN - Vietnam 264
DE - Germania 190
FI - Finlandia 109
IE - Irlanda 68
IN - India 68
FR - Francia 64
GB - Regno Unito 63
CI - Costa d'Avorio 61
CA - Canada 57
NL - Olanda 44
AR - Argentina 37
SE - Svezia 36
MX - Messico 35
PL - Polonia 28
BD - Bangladesh 26
ES - Italia 23
JP - Giappone 22
KR - Corea 21
ZA - Sudafrica 20
TR - Turchia 14
ID - Indonesia 13
EC - Ecuador 12
AT - Austria 11
PK - Pakistan 11
IQ - Iraq 10
UA - Ucraina 9
LT - Lituania 8
VE - Venezuela 8
CO - Colombia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
PE - Perù 6
PY - Paraguay 6
CL - Cile 5
EG - Egitto 5
MA - Marocco 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
RO - Romania 4
SA - Arabia Saudita 4
TN - Tunisia 4
ET - Etiopia 3
GA - Gabon 3
KE - Kenya 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
OM - Oman 3
SN - Senegal 3
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
GY - Guiana 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
NA - Namibia 2
NP - Nepal 2
NR - Nauru 2
PA - Panama 2
TZ - Tanzania 2
UG - Uganda 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
KI - Kiribati 1
MD - Moldavia 1
MQ - Martinica 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 8.528
Città #
Singapore 816
Moscow 293
Hong Kong 270
Ashburn 255
Chandler 232
Beijing 191
Santa Clara 133
Hefei 109
Ho Chi Minh City 92
Naples 91
Los Angeles 79
Munich 78
San Jose 69
Napoli 65
Millbury 64
Dong Ket 60
The Dalles 57
Boston 55
Nanjing 55
Seattle 47
New York 44
Des Moines 43
Redondo Beach 43
Hanoi 41
Lawrence 40
Princeton 40
Turku 40
São Paulo 39
Helsinki 37
Buffalo 36
Rome 33
Amsterdam 32
Wilmington 32
Dallas 31
Frankfurt am Main 23
Chicago 22
Pune 22
Tokyo 22
Mexico City 21
Montreal 21
Seoul 19
Warsaw 19
Denver 16
Nuremberg 16
Chennai 15
Brooklyn 14
Dublin 14
Falls Church 14
Houston 14
Ottawa 14
Kochi 13
London 13
Orem 13
Poplar 13
Stockholm 13
Tianjin 13
Atlanta 12
Curitiba 12
Hebei 12
Redwood City 12
Council Bluffs 11
Guangzhou 11
Toronto 11
Fairfield 10
Falkenstein 10
Lappeenranta 10
Ankara 9
Dhaka 9
Düsseldorf 9
Haiphong 9
Johannesburg 9
Menlo Park 9
Nanchang 9
Changsha 8
Manchester 8
Shanghai 8
Shenyang 8
Angri 7
Boardman 7
Jacksonville 7
Salerno 7
Woodbridge 7
Belo Horizonte 6
Eboli 6
Jiaxing 6
Norwalk 6
Phoenix 6
Ribeirão Preto 6
Secaucus 6
Vienna 6
Bexley 5
Biên Hòa 5
Brasília 5
Buenos Aires 5
Cambridge 5
Cape Town 5
Ferrara 5
Hangzhou 5
Jaboatão dos Guararapes 5
Kronberg 5
Totale 4.345
Nome #
Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis 156
Immunosuppressive therapy with rituximab in common variable immunodeficiency 148
Combating Actions of Green 2D-Materials on Gram Positive and Negative Bacteria and Enveloped Viruses 148
SARS-CoV-2 Spike Protein Activates Human Lung Macrophages 145
Innate Immune Cells in Melanoma: Implications for Immunotherapy 143
Secreted phospholipases A2 in hereditary angioedema with C1-inhibitor deficiency 138
Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14(+) CD1c(+) Monocytes 133
Mast cells have a protumorigenic role in human thyroid cancer. 132
Hereditary angioedema attack: what happens to vasoactive mediators? 132
Cardiotoxicity of immune checkpoint inhibitors 126
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 125
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue 123
Potential involvement of neutrophils in human thyroid cancer 121
The human heart can be both the site and the target of anaphylactic reactions. 120
Epigenetics: an Opportunity to Shape Innate and Adaptive Immune Responses 118
Macrophage-polarizing stimuli differentially modulate the inflammatory profile induced by the secreted phospholipase A2 group IA in human lung macrophages. GALDIERO AND FERRARA ARE CO-FIRST AUTHORS 117
Anaplastic Thyroid Cancer Cells Induce the Release of Mitochondrial Extracellular DNA Traps by Viable Neutrophils 116
“La diagnostica molecolare (CRD) nel laboratorio di allergologia: valutazione di allergeni ricombinanti in pazienti con allergie agli inalanti”. 115
Recombinant allergens in the diagnosis of pollen-allergic patients: comparison with natural allergens extracts 114
Size-based effects of anthropogenic ultrafine particles on activation of human lung macrophages 113
PD-L1+ neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab 108
Group V Secreted Phospholipase A2 Induces the Release of Proangiogenic and Antiangiogenic Factors by Human Neutrophils 108
Human cardiac mast cells in anaphylaxis 107
GM-CSF and IL-3 Modulate Human Monocyte TNF-α Production and Renewal in In Vitro Models of Trained Immunity 107
Innate effector cells in angiogenesis and lymphangiogenesis 107
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis. (VARRICCHI AUTORE CORRISPONDENTE) 107
Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy and future perspectives 105
Angiogenesis, lymphangiogenesis and atopic dermatitis. 104
LOFFREDO and GALDIERO are CO-FIRST AUTHORS. Eosinophils: The unsung heroes in cancer? 104
LOFFREDO is CO-FIRST AUTHOR. Are Mast Cells MASTers in Cancer? 103
Role of Inflammation in Benign Salivary Gland Tumor Etiopathogenesis: An Evaluation through the Blood Inflammatory Biomarkers 102
First Report of De Novo Nivolumab-Induced Oligoarthritis in a Young Man With Relapsing Classic Hodgkin Lymphoma 102
VEGF-A in cardiomyocytes and heart diseases 101
Human cardiac mast cells in anaphylaxis 100
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 100
The broad spectrum of cardiotoxicities from immunotherapies 99
LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation. GALDIERO IS CO-LAST AUTHOR 98
Neutrophil exhaustion and impaired functionality in psoriatic arthritis patients 96
Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer 96
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. (VARRICCHI ULTIMO AUTORE E AUTORE CORRISPONDENTE) 96
Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019 94
Innate immune modulation by GM-CSF and IL-3 in health and disease 93
The Interplay between the Immune and the Endocannabinoid Systems in Cancer 93
Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer 92
Controversial role of mast cells in skin cancers 91
Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment 91
Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature 91
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 89
Neutrophil Extracellular Traps, Angiogenesis and Cancer 89
Recombinant allergens in the diagnosis of pollen-allergic patients: comparison with natural allergens extracts. 88
Roles of Immune Cells in Hereditary Angioedema 88
Tumor associated macrophages and neutrophils in cancer 87
Functional Modulation of Human Macrophages by Secreted Phospholipases A2: Implications in Cancer 87
Roles of mast cells and their mediators in human thyroid carcinomas. 86
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps 85
Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma 85
Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors 81
Neutrophils in innate and adaptive immunity 80
Mast Cells in Early Rheumatoid Arthritis 80
Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review 80
Ca2+-Dependent Processes of Innate Immunity in IBD 79
ROLES OF MAST CELLS AND THEIR MEDIATORS IN HUMAN THYROID CARCINOMAS 78
Neutrophil Extracellular Traps in Cancer 78
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis 77
Mast cells play (a) protumorigenic roles in human thyroid cancer. 75
Mast cells and basophils in angiogenesis: bridging the gap between inflammation and tumors 74
Macrophage plasticity and polarization in tissue repair and remodelling 74
Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation 73
Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence 72
CMTM4 as a new partner for IL-17 receptor: Adding a piece in the puzzle of IL17-driven diseases 70
GALDIERO is CO-FIRST AUTHOR. Phagocytes as Corrupted Policemen in Cancer-Related Inflammation 70
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer 69
Immune checkpoint inhibitors-induced autoimmunity: The impact of gender 69
Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors: It Is Now Time for Cardio-Immuno-Oncology 67
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 67
New insight in endocrine-related adverse events associated to immune checkpoint blockade 66
Differential activation of monocytes and PMNs in orofacial granulomatosis patients induced by bacterial and non-bacterial stimuli 65
Cancer Inflammation and Cytokines 62
Tumor-associated Macrophages in Cancer Growth and Progression 61
Immune and inflammatory cells in thyroid cancer microenvironment 61
Are Basophils and Mast Cells Masters in HIV Infection? 60
Roles of neutrophils in cancer growth and progression 57
Hypersensitivity reactions to antineoplastic drugs. I. General aspects,Reazioni di ipersensibilit{\`a} a farmaci antineoplastici. I. aspetti generali 55
The immune network in thyroid cancer 53
Gender dimorphism in IgA subclasses in T2-high asthma 53
Editorial: Extracellular traps in cancer immunity and immunotherapy 51
Occurrence and significance of tumor-Associated neutrophils in patients with colorectal cancer 49
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors 49
The immune landscape of thyroid cancer in the context of immune checkpoint inhibition 48
Cardiac Toxicity of Immune Checkpoint Inhibitors: Cardio-Oncology Meets Immunology 45
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 44
Novel actors on the stage of cardiac dysfunction induced by anti-PD1 oncological treatments 44
Tumor associated macrophages and neutrophils in tumor progression. 43
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 43
Macrophage Plasticity and Polarization: Relevance to Biomaterials 41
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 41
Reazione da ipersensibilità a farmaci. Parte I. Manifestazioni cutanee. 40
Histamine as a mediator of cross-talk between human lung mast cells and macrophages 38
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity 38
Polarized activation of macrophages 35
Totale 8.717
Categoria #
all - tutte 29.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 25 7 14 13 10 65
2021/2022452 15 16 7 12 5 11 8 30 63 26 99 160
2022/2023576 83 36 34 28 92 66 7 67 85 34 34 10
2023/2024583 13 60 53 35 38 99 20 131 9 8 80 37
2024/20252.898 143 126 16 46 47 217 309 172 160 272 1.077 313
2025/20263.525 624 341 595 606 1.020 206 133 0 0 0 0 0
Totale 8.731